GlucoTrack
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlucoTrack and other ETFs, options, and stocks.About GCTK
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid.
CEOPaul V. Goode
CEOPaul V. Goode
Employees11
Employees11
HeadquartersRutherford, New Jersey
HeadquartersRutherford, New Jersey
Founded2001
Founded2001
Employees11
Employees11
GCTK Key Statistics
Market cap3.55M
Market cap3.55M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume283.62K
Average volume283.62K
High today$3.85
High today$3.85
Low today$3.43
Low today$3.43
Open price$3.44
Open price$3.44
Volume50.13K
Volume50.13K
52 Week high$140.16
52 Week high$140.16
52 Week low$3.21
52 Week low$3.21
Stock Snapshot
The current GlucoTrack(GCTK) stock price is $3.90, with a market capitalization of 3.55M.
As of 2026-01-22, GlucoTrack(GCTK) stock has fluctuated between $3.43 and $3.85. The current price stands at $3.90, placing the stock +13.7% above today's low and +1.3% off the high.
The GlucoTrack(GCTK)'s current trading volume is 50.13K, compared to an average daily volume of 283.62K.
In the last year, GlucoTrack(GCTK) shares hit a 52-week high of $140.16 and a 52-week low of $3.21.
In the last year, GlucoTrack(GCTK) shares hit a 52-week high of $140.16 and a 52-week low of $3.21.
People also own
Based on the portfolios of people who own GCTK. This list is generated using Robinhood data, and it’s not a recommendation.